Advances in antioxidative therapy of multiple sclerosis

Area of Science:

• Neuroimmunology
• Neurodegeneration
• Oxidative Stress

Background:

• Multiple sclerosis (MS) is a chronic central nervous system (CNS) disease with limited treatment options.
• Oxidative stress, driven by reactive oxygen and nitrogen species (ROS/RNS), is a key factor in MS pathogenesis, causing oligodendrocyte damage and axonal injury.
• Activated microglia and macrophages release inflammatory mediators, exacerbating neurodegeneration in chronic MS stages.

Purpose of the Study:

• To review the antioxidative system within the CNS.
• To discuss potential antioxidative therapies for MS.
• To highlight the need for further research into antioxidants for MS treatment.

Main Methods:

• Literature review of CNS antioxidative systems.
• Analysis of oxidative stress mechanisms in MS pathogenesis.
• Evaluation of existing and proposed antioxidant therapies for MS.

Main Results:

• Oxidative stress and excitotoxicity contribute to neurodegeneration, including axon and neuron loss in MS.
• Antioxidants and diet supplementation are considered potential therapeutic strategies.
• Current research on exogenous compounds for MS treatment requires further investigation.

Conclusions:

• Understanding the role of antioxidants in MS neurodegeneration is crucial.
• Further research is needed to establish novel therapeutic goals and provide benefits for MS patients.
• Antioxidative strategies hold promise for improving treatment outcomes in multiple sclerosis.